Live Quote · NASDAQAVTXHealthcare· Biotechnology

Avalo Therapeutics, Inc.

$6.76▲ 0.15%(+$0.01)
MKT CAP $390.88MNEXT EARNINGS Mar 22, 2027
50%
Bullish
TickerSpark Score
47/100
▌ Weak
70
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVTX research report →

Analyst Price Target
$28.40+320.1% vs. today

Range $10 – $48

Analyst RatingBuy
6 Buy3 Hold1 Sell

Price Chart

-61.89% · this period
$22.87$14.75$6.63Nov 20May 26Nov 20
52-Week Range1% of range
Low
$6.53
Current
$6.76
High
$24.27